Moderna’s mRNA flu vaccine faces FDA advisory panel scrutiny
Moderna’s mRNA flu vaccine faces FDA advisory panel scrutiny
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.